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Outline
• Definitions
• Nanoparticle toxicity
• Current regulatory environment
• Worker exposure to nanoparticles
– Airborne exposure
– Dermal exposure
• Control of exposures
• Best practices to follow when working with 
nanoparticles
Categories of Nanoparticles
• Naturally-occurring (e.g., forest fires, 
volcanoes)
• Industrial (e.g., welding fume, diesel 
exhaust)
• Engineered (e.g., carbon nanotubes, 
fullerenes)
Nanoparticles
in the Work Environment
Well-known occupational & environmental 
exposures
• asbestos 
• silica flour
• flour dust 
• combustion products
– welding fume
– diesel exhaust
– asphalt fume
Oberdorster, in BIA report 7/2003e
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Crucial Factor in Nanoparticle Toxicity
Question:
What makes nanoparticles different from 
larger particles of the same composition?
Answer:
Particle surface-to-volume ratio increases as 
the particle diameter decreases
Consider three cases:
Case 1:
A single cube, 1 m length per side
n = 1 particle L = 1 m
SA = 6 m2 V = 1 m3
SA/V = 6/1 = 6 m-1
Case 2:
Slice the single large cube 1,000,000 times along each axis
n = 106 x 106 x 106 = 1018 particles
L = 1 μm
SA = 6 x 10-6  m x 10-6 m = 6 x 10-12 m2
V = 10-18 m3
SA/V = 6 x 10-12 m2/ 10-18 m3 = 6 x 106 m-1
n = 109 x 109 x 109 = 1027 particles
L = 1 nm
SA = 6 x 10-9  m x 10-9 m = 6 x 10-18 m2
V = 10-27 m3
SA/V = 6 x 10-18 m2/ 10-27 m3 = 6 x 109 m-1
Case 3:
Slice each small cube 1,000 times along each axis

The Message
• Surface area and particle number become 
much more important as the particles 
become smaller, compared to mass
• Toxicological end points that depend on 
mass may be less important than end 
points that depend on surface area or 
number
Particle Mobility
• As particles reach the nanometer size 
range, they may become more biologically 
mobile
– Cross cellular boundaries from the alveolar 
region into the circulatory system
– Pass through the skin
– Travel through the olfactory nerve to the brain
Emphasis on CNT Toxicity
• Many studies published in the last 2-3 years
• End point studied:
– Fibrosis
– Inflammation
• Lung tissue
• Cardiac tissue
• Mesothelioma
• Donaldson: “…there is no experience of a 
workforce being potentially exposed to a 
biopersistent fibre of this degree of thinness.”
Donaldson, et al., Carbon nanotubes: a review of their properties in relation to 
pulmonary toxicology and workplace safety, Toxicol Sci 92: 5-22, 2006
NIOSH Inhalation Studies
• Purified SWCNT’s
• Mice
• Aspiration – 0,10,20,40 μg/mouse
• Ultrafine carbon black and SiO2 used as 
control
• Dose equivalent to a worker exposed to 
the graphite Permissible Exposure Limit (5 
mg/m3) for 20 work days
Effects on Lung
• Both inflammation (acute response) and 
fibrosis (chronic response) were found
• Effects were dose-dependent
• No fibrosis and greatly reduced 
inflammation found with the reference 
materials
Is This of Concern?
• Mouse dose equivalent to airborne 
concentration of 5 mg/m3 for 8 h/day for 20 
days
• 5 mg/m3 CNT → 1017 CNT/m3
= 1011 CNT/cm3!! 
– Highest concentrations we have measured 
anywhere in any lab :
< 106 particles/cm3
Cardiac Tissue Inflammation
• NIOSH study – same protocol as previous study
• “A single intrapharyngeal instillation of SWCNTs 
induced activation of heme oxygenase-1 (HO-1), a 
marker of oxidative insults, in lung, aorta, and heart 
tissue in HO-1 reporter transgenic mice. Furthermore, 
we found that C57BL/6 mice, exposed to SWCNT (10 
and 40 μg/mouse), developed aortic mtDNA damage 
at 7, 28, and 60 days after exposure.“
Li, et al., Cardiovascular Effects of Pulmonary Exposure to Single-Wall Carbon Nanotubes, Env Health Perspect 115: 377-82, 
2007
CNTs cause Mesothelioma?
• Carbon nanotubes introduced into the 
abdominal cavity of mice show 
asbestos-like pathogenicity in a pilot 
study. 
• Induction of mesothelioma in p53+/-
mouse by intraperitoneal application 
of multi-wall carbon nanotube. Takagi, et al., 
Induction of mesothelioma in p53+/- mouse by intraperitoneal application of 
multi-wall carbon nanotube J. Toxicol. Sci 33:105-15, 2008.
•Poland, et al., Carbon nanotubes 
introduced into the abdominal cavity of 
mice show asbestos-like pathogenicity in 
a pilot study  Nature Nano. 3:423-8, 
2008.
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Current Status - Regulations
• Few, if any, regulations exist specifically 
for engineered nanoparticles
• No exposure limits, no emission limits, no 
disposal regulations
• In the U.S., EPA, the state of CA and the 
city of Berkeley are now requiring CNT 
manufacturers to submit information
• Manufacturers and users must operate in 
an atmosphere of uncertainty
Recent Regulatory Activity in the United States
• EPA - Toxic Substances Control Act Inventory Status of 
Carbon Nanotubes – 31 Oct 2008
“This document gives notice of the Toxic Substances Control 
Act (TSCA) requirements potentially applicable to carbon 
nanotubes (CNTs). EPA generally considers CNTs to be 
chemical substances distinct from graphite or other allotropes 
of carbon listed on the TSCA Inventory. Many CNTs may 
therefore be new chemicals under TSCA section 5. 
Manufacturers or importers of CNTs not on the TSCA 
Inventory must submit a premanufacture notice (PMN) (or 
applicable exemption) under TSCA section 5…”
Recent Regulatory Activity in the United States, 
Cont.
On January 22, 2009, California's Department of 
Toxic Substances Control (DTSC) sent a formal 
request to several California manufacturers 
and/or importers of carbon nanotubes seeking 
information regarding analytical test methods, 
environmental fate and transport, and other 
relevant environmental, health, and safety 
information regarding carbon nanotubes. 
CA Questions to Manufacturers, Cont.
• Recipients had one year (until Jan 22, 
2010) to supply the requested information
• 20 companies/universities/labs responded
• Submitted information available on-line;
http://www.dtsc.ca.gov/TechnologyDevelop
ment/Nanotechnology/nanocallin.cfm
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Olfactory Nerve Exposure
and 
Central Nervous System Effects
Cross-section of an Alveolus
Shows a very 
thin (500 nm) 
separation 
between 
blood and air. 
An SEM 
image of the 
alveoli is 
shown in the 
inset
Hoet et al. J Nanobiotech 2004.

Alveolar Macrophage Attacking e. coli
Alveolar Macrophage Attacking 
an Asbestos Fiber
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Schematic of Human Skin
Stratum 
corneum, top of 
the five layers 
making 
epidermis, is 
shed off and 
replaced every 
two weeks. 
Depending on 
the part of the 
body its 
thickness varies 
from 0.05 mm to 
1.5 mm.
Hoet et al. J Nanobiotech 2004.
Dermal 
Exposure
Tinkle et al
EHP 2003
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Control of Airborne Exposures
• Airborne nanoparticles behave very much 
like gas molecules
• Therefore, standard engineering control 
methods developed for gases should work 
well to protect workers from exposure to 
nanoparticles
• One possible exception – respirators
• Less confidence regarding environmental 
controls
Methods of Control
Hierarchy of controls
• Engineering controls
– Substitution
– Isolation
– Ventilation
• General exhaust ventilation
• Local exhaust ventilation
• Administrative controls
– Worker training
– Medical monitoring
– scheduling

Control of Airborne Exposures
See Candace’s talk this afternoon, for more 
information on exposure assessment and 
control
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Document Outline
1. Introduction
2. Basic Premises
3. Occupational Hygiene Resources 
Available to CHN Researchers
4. Routine R&D Laboratory Operations
5. Management of Nanomaterials 
6. Management of Nanomaterial Spills
NIOSH/CHN Best Practices Document
• Safe Practices for Working with Engineered 
Nanomaterials in Research Laboratories
• Michael Ellenbecker and Su-Jung (Candace) 
Tsai
• Report submitted to NIOSH – 30 September 09 
– 80 pages,~100 references
• Meant to be the most comprehensive guide 
available
• Published in late 2010
• Watch for it!
Summary
• Toxicity of most engineered nanoparticles 
is uncertain at this time
– CNTs in particular look very problematic
– Many newer particles not studied to date
• Measurements performed by our lab, and 
others, indicate the potential for significant 
occupational exposure
• Regulations will be a long time coming
Summary, Continued
• We must take a precautionary, proactive 
approach to minimize exposures to 
workers and the general public
• Engineering controls and good work 
practices are available and must be used 
to the greatest extent possible
• Engineered nanoparticles have the 
potential to benefit society greatly; it is the 
responsibility of the occupational health 
community to ensure that they are used 
safely
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